Loading quotes...
Forecast
| Buy |
0 |
| Hold |
1 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Auxly Cannabis conducts 14:1 share consolidation and resumes trading
The Auxly Cannabis Group has, after shareholder approval, consolidated its shares on a 14:1 basis and resumed trading of the new common shares. Details of the measure were published on July 22; the transfer agent is issuing new DRS certificates. Outstanding convertible notes will be adjusted accordingly, and the company does not disclose the total number of shares before or after the consolidation. » More on de.investing.com
Auxly Cannabis completes 14:1 share consolidation
Auxly Cannabis is carrying out a 14-for-1 share consolidation; consolidated trading on the Toronto Stock Exchange is expected to begin on July 28, 2026. The number of outstanding common shares will fall from about 1.42 billion to roughly 101.3 million, while percentage ownership and voting rights of shareholders remain unchanged and fractional shares will be rounded down. The shares will remain listed under the symbols XLY (TSX) and CBWTF (OTCQB); new CUSIP and ISIN numbers have been provided. Convertible securities will be adjusted on a proportional basis, and management stresses that this is not being done in preparation for a financing. » More on de.investing.com
Auxly Cannabis posts record revenue in first quarter 2026
Auxly Cannabis reported net revenue of CAD 39.8m for Q1 2026 (+22% YoY), well above industry growth and ahead of the CAD 35.9m forecast. Gross margin rose to 55% (+700 basis points) and adjusted EBITDA climbed 65% to CAD 12.3m; operating cash flow more than doubled to CAD 11.3m. Cash position was over CAD 42m with total debt of CAD 45m, while earnings per share remained unchanged and the stock reacted neutrally. » More on de.investing.com
Auxly Cannabis reports strong growth and record margins in Q4 2025
Auxly Cannabis reported Q4 2025 revenue of CAD 40.1m (+16% year-on-year) and EPS of CAD 0.001; the company recorded 24% revenue growth for 2025 and adjusted EBITDA of CAD 43.8m. Gross margin rose 800 basis points to 54% and Q4 adjusted EBITDA was CAD 12.5m. Despite a slight revenue miss versus guidance, the stock rose 7.69% pre-market; for 2026 Auxly is targeting further market growth, stable margins and CAD 10–12m in capex. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 29.88M | 70.46% |
| Gross profit | 9.1M | 134.34% |
| Net profit | 8.22M | 8.68% |
| EBITDA | 1.68M | 84.42% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €237.73M |
Number of shares | 103.24M |
52-week high/low | €2.51 - €0.11 |
| Dividends | No |
Beta | 1.20 |
P/E ratio | 14.39 |
PEG ratio | -0.30 |
P/B ratio | 1.89 |
P/S ratio | 2.11 |
Company profile
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.
| Name | AUXLY CANNABIS GRP |
| CEO | Hugo Alves |
| Headquarters | Toronto,
on Canada |
| Website | |
| Sector | Consumer Staples |
| Industry | Food Products |
| IPO | 07/07/2022 |
| Employees | 446 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Toronto Stock Exchange | XLY.TO |
Pnk | CBWTF |
Frankfurt | 3KF.F |
Düsseldorf | 3KF.DU |
München | 3KF.MU |